Terray Therapeutics
Develops small-molecule therapeutics using artificial intelligence and automation.
Company facts
- Founded
- 2018
- Employees
- 137
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $120M · 2024
Develops small-molecule therapeutics using artificial intelligence and automation.
Company facts